Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug combo shows promise against deadly gut infection

NCT ID NCT05304715

Completed Disease control Sponsor: Hellenic Institute for the Study of Sepsis Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding the drug bezlotoxumab to standard treatment could prevent serious outcomes in people with a severe C. diff infection. Researchers used a special score to identify 44 high-risk patients. The goal was to see if the drug reduced organ failure, infection return, or death within 40 days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLOSTRIDIOIDES DIFFICILE INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Clostridium difficile colitis Clostridium infectious disease multiple organ dysfunction syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CLOSTRIDIOIDES DIFFICILE INFECTION CLOSTRIDIOIDES DIFFICILE INFECTION RECURRENCE MORTALITY ORGAN DYSFUNCTION SYNDROME STOOL MICROBIOME

Contacts and locations

Locations

  • 1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki

    Thessaloniki, 54621, Greece

  • 1st Department of Internal Medicine, General University Hospital of Ioannina

    Ioannina, 45500, Greece

  • 1st Department of Internal Medicine, THRIASIO General Hospital of Eleusis

    Athens, 10918, Greece

  • 1st University Department of Internal Medicine, LAIKO General Hospital of Athens,

    Athens, 11527, Greece

  • 1st University Department of Propaedeutic Surgery, IPPOKRATEION General Hospital

    Athens, 11527, Greece

  • 2nd Department of Internal Medicine, Thriasio General Hospital

    Athens, 10918, Greece

  • 2nd Department of Internal Medicine, Tzanneion General Hospital

    Piraeus, 18536, Greece

  • 2nd Department of Internal Medicine, University General Hospital of Alexandroupolis

    Alexandroupoli, 68100, Greece

  • 4th Department of Internal Medicine, Attikon University Hospital

    Athens, 12462, Greece

  • Department of Internal Medicine, Larissa University Hospital

    Larissa, 41334, Greece

  • Department of Internal Medicine, University General Hospital of Patras PANAGIA I VOITHIA

    Pátrai, 26504, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.